the Rest Peptide Mechanism Weight Loss Potential Typical Use Cagrilintide Amylin analog Moderate to high (especially in combo) Weight loss adjunct Semaglutide GLP-1 agonist High Obesity, type 2 diabetes Tirzepatide GIP/GLP-1 dual agonist Very high Obesity, type 2 diabetes Retatrutide GIP/GLP-1/Glucagon triple agonist Extremely high (research stage) Experimental weight loss agent Future of Cagrilintide and Its Dosage Schedules As the body of research grows, Cagrilintide dosage schedules will likely become more refined based on user response and clinical trials
[3] Lee JO, Kim Y, Lee JM, Suk JM, Jung I, Choi SY, Yoo KH, Seok J, Kim BJ
Structural peptides like BPC-157, which have minimal CNS penetration, carry low interaction risk with SSRIs or SNRIs
Learn more Semaglutide is a GLP-1 (glucagon-like-peptide-1) receptor agonist and is FDA approved for weight loss